Core Viewpoint - The company plans to sell a significant number of shares in various companies based on market conditions, which is expected to yield substantial profits exceeding 50% of its audited net profit from the last year [1] Group 1: Share Sales - The company intends to sell 8.686 million shares of Guizhou Yibai Pharmaceutical Co., Ltd. [1] - The company plans to sell 970,600 shares of Aorui De Optoelectronics Co., Ltd. [1] - The company will sell 7,716 shares of China Ping An Insurance (Group) Company [1] - The company aims to sell 4.7122 million shares of Hunan Erkang Pharmaceutical Co., Ltd. [1] Group 2: Financial Impact - The estimated profit from the sale of these shares, after deducting holding costs and related taxes, is projected to account for over 50% of the company's audited net profit from the previous year [1]